| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |